టాప్ స్టోరీస్

Aurobindo Pharma shares gain on U.S. FDA’s VAI classification of oral solid dosage unit

08:59
Aurobindo Pharma shares gain on U.S. FDA’s VAI classification of oral solid dosage unit

Around 2 p.m., Aurobindo Pharma shares were more than 3% higher at ₹1,475 each after touching the 52 week high of ₹1,481.80

Full story

Debug: backend attempts
http://api:8080/v1/feed/items/f8f70541-1009-4452-bfb1-ae3f772ee9c5?tenant_id=047dc75b-5cff-41f7-b49d-b10cc76161ad&language_code=te200
{"requested_language":"te","item":{"id":"f8f70541-1009-4452-bfb1-ae3f772ee9c5","slug":"aurobindo-pharma-shares-gain-on-us-fdas-vai-classification-of-oral-solid-dosage-f8f70541","category":"top-stories","published_at":"2026-05-06T08:59:03Z","title":"Aurobindo Pharma shares gain on U.S. FDA’s VAI classification of oral solid dosage unit","summary":"Around 2 p.m., Aurobindo Pharma shares were more than 3% higher at ₹1,475 each after touching the 52 week high of ₹1,481.80","source_url":"https://www.thehindu.com/business/aurobindo-pharma-shares-gain-on-us-fdas-vai-classification-of-oral-solid-dosage-unit/article70946420.ece","source_name":"www.thehindu.com","image_url":"https://th-i.thgim.com/public/incoming/cyn3k8/article70946442.ece/alternates/LANDSCAPE_1200/IMG_images__2__2_1_8BEKSO8I.jpg","served_language":"en","is_fallback":true,"available_languages":["en"]}}